• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishDashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form 4 filed by XPAC Sponsor LLC

    8/20/21 4:02:43 PM ET
    $XP
    Investment Bankers/Brokers/Service
    Finance
    Get the next $XP alert in real time by email
    SEC FORM 4 SEC Form 4
    FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
    Washington, D.C. 20549

    STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

    Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
    or Section 30(h) of the Investment Company Act of 1940
    OMB APPROVAL
    OMB Number: 3235-0287
    Estimated average burden
    hours per response: 0.5
      
    Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
    1. Name and Address of Reporting Person*
    XPAC Sponsor LLC

    (Last) (First) (Middle)
    55 WEST 46TH STREET, 30TH FLOOR

    (Street)
    NEW YORK, NY 10036

    (City) (State) (Zip)
    2. Issuer Name and Ticker or Trading Symbol
    XPAC Acquisition Corp. [ XPAX ]
    5. Relationship of Reporting Person(s) to Issuer
    (Check all applicable)
    Director X 10% Owner
    Officer (give title below) Other (specify below)
    3. Date of Earliest Transaction (Month/Day/Year)
    08/19/2021
    4. If Amendment, Date of Original Filed (Month/Day/Year)
    6. Individual or Joint/Group Filing (Check Applicable Line)
    Form filed by One Reporting Person
    X Form filed by More than One Reporting Person
    Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
    1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
    Code V Amount (A) or (D) Price
    Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
    (e.g., puts, calls, warrants, options, convertible securities)
    1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
    Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
    Class B ordinary shares (1) 08/19/2021 J(2) 259,717 (1) (1) Class A ordinary shares 259,717 (2) 5,400,283 D(3)
    1. Name and Address of Reporting Person*
    XPAC Sponsor LLC

    (Last) (First) (Middle)
    55 WEST 46TH STREET, 30TH FLOOR

    (Street)
    NEW YORK, NY 10036

    (City) (State) (Zip)
    1. Name and Address of Reporting Person*
    XP Inc.

    (Last) (First) (Middle)
    C/O XPAC SPONSOR LLC.
    55 WEST 46TH STREET, 30TH FLOOR

    (Street)
    NEW YORK, NY 10036

    (City) (State) (Zip)
    Explanation of Responses:
    1. As described in the issuer's registration statement on Form S-1 (File No. 333-256097) under the heading "Description of Securities--Founder Shares," the Class B ordinary shares, par value $0.0001 per share, of the issuer will automatically convert into Class A ordinary shares, par value $0.0001 per share, of the issuer at the time of the issuer's initial business combination, or earlier at the option of the holder, on a one-for-one basis, subject to certain adjustment, and have no expiration date.
    2. Forfeiture and cancellation of 259,717 Class B ordinary shares for no consideration because the underwriter for the issuer's initial public offering did not fully exercise the over-allotment option.
    3. XPAC Sponsor LLC (the "Sponsor") is the record holder of the Class B ordinary shares reported herein. The sole member of the Sponsor, XP Inc., by virtue of its control over the Sponsor, may be deemed to beneficially own shares held by the Sponsor.
    XPAC Sponsor LLC, By: /s/ Chu Chiu Kong, as Manager 08/20/2021
    XP Inc., By: /s/ Fabricio Cunha de Almeida, as General Counsel and Director 08/20/2021
    ** Signature of Reporting Person Date
    Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
    * If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
    ** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
    Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
    Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
    Get the next $XP alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $XP

    DatePrice TargetRatingAnalyst
    6/4/2025$23.00Neutral → Buy
    Goldman
    5/13/2025$24.00Equal-Weight → Overweight
    Morgan Stanley
    3/18/2025$20.00Outperform
    Itau BBA
    1/24/2025$19.00 → $16.00Neutral → Buy
    UBS
    12/10/2024$25.00 → $16.00Buy → Neutral
    BofA Securities
    7/11/2024$30.00 → $21.00Buy → Neutral
    UBS
    4/30/2024$30.00 → $23.00Buy → Neutral
    Goldman
    4/23/2024$31.00 → $24.00Overweight → Equal-Weight
    Morgan Stanley
    More analyst ratings